August 2012 Br J Cardiol 2012;19:116
Danny Lim, Dev Katarey; Drs Raj Mohindra, Stuart Russell, and Andreas Wolff
Optimised beta blocker therapy in heart failure: is there space for additional heart rate control? Dear Sirs, We undertook a similar audit to Russell et al.1 within the heart failure service of a district general hospital auditing the case notes of 96 patients attending over three months. Applying the SHIFT inclusion and exclusion criteria, we identified only seven patients (6.7%) eligible for ivabradine. Using the SHIFT dataset the number needed to treat to prevent a single hospitalisation due to heart failure was 22.2 Extrapolating our data, over 12 months, we would expect to identify approximately 28 suitable patients. Treating 28 patients
March 2010 Br J Cardiol 2010;17:89–92
Joanna C E-S Lim, Ajay Suri, Sangeetha Sornalingham, Tuan Peng Chua
We audited management of AF at the Royal Surrey County Hospital against standards derived from the NICE guidelines. Fifty-nine of the 663 patients (8.9%) presenting to the acute medical take during the month of May 2008 had a documented diagnosis of AF, 10% of whom presented with a new diagnosis of AF and 90% of whom had a pre-existing diagnosis. The case notes of these 59 patients were reviewed. All patients with a new diagnosis of AF were managed consistently with the NICE guidelines. Compliance for patients with pre-existing AF was much lower. Eighteen out of 31 patients (58%) with pre-existing AF were found to be on digoxin monotherapy on
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits